293 related articles for article (PubMed ID: 35219932)
1. COVID-19 and thrombosis: The role of hemodynamics.
Sastry S; Cuomo F; Muthusamy J
Thromb Res; 2022 Apr; 212():51-57. PubMed ID: 35219932
[TBL] [Abstract][Full Text] [Related]
2. COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past.
Mehta JL; Calcaterra G; Bassareo PP
Clin Cardiol; 2020 Dec; 43(12):1362-1367. PubMed ID: 33176009
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
5. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Levi M; Iba T
Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
[TBL] [Abstract][Full Text] [Related]
7. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.
Wolberg AS; Aleman MM; Leiderman K; Machlus KR
Anesth Analg; 2012 Feb; 114(2):275-85. PubMed ID: 22104070
[TBL] [Abstract][Full Text] [Related]
8. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 coagulopathy - what should we treat?
Chowdary P
Exp Physiol; 2022 Jul; 107(7):749-758. PubMed ID: 35733235
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
[TBL] [Abstract][Full Text] [Related]
11. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
Shazley O; Alshazley M
Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
[TBL] [Abstract][Full Text] [Related]
12. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Iba T; Connors JM; Levy JH
Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
[TBL] [Abstract][Full Text] [Related]
13. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
AlNafea HM; Korish AA
Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
[TBL] [Abstract][Full Text] [Related]
14. Venous Thrombosis and SARS-CoV-2.
Zdanyte M; Rath D; Gawaz M; Geisler T
Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
[TBL] [Abstract][Full Text] [Related]
15. Brachial Artery Thrombosis in a Covid-19 Positive Patient with Thoracic Outlet Syndrome.
Heineman N; Koehler D
Iowa Orthop J; 2021 Dec; 41(2):1-5. PubMed ID: 34924863
[TBL] [Abstract][Full Text] [Related]
16. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.
Chang JC
Vasc Health Risk Manag; 2021; 17():273-298. PubMed ID: 34103921
[TBL] [Abstract][Full Text] [Related]
18. Multiphysics and multiscale modeling of microthrombosis in COVID-19.
Li H; Deng Y; Li Z; Dorken Gallastegi A; Mantzoros CS; Frydman GH; Karniadakis GE
PLoS Comput Biol; 2022 Mar; 18(3):e1009892. PubMed ID: 35255089
[TBL] [Abstract][Full Text] [Related]
19. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
Savla SR; Prabhavalkar KS; Bhatt LK
Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and coagulopathy.
Sarkar M; Madabhavi IV; Quy PN; Govindagoudar MB
Clin Respir J; 2021 Dec; 15(12):1259-1274. PubMed ID: 34399021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
